FDA approves Vertex’s cystic fibrosis therapy Orkambi for children under six
The US Food and Drug Administration (FDA) has granted approval to Vertex Pharmaceuticals for the use of its Orkambi (lumacaftor/ivacaftor)…
cystic fibrosis
-
-
Boehringer forms new alliance to develop gene therapy
Boehringer Ingelheim has entered a global partnership with the UK Cystic Fibrosis Gene Therapy Consortium (GTC), Imperial Innovations and Oxford…
